Cirencester, United Kingdom
OBS Medical Ltd, founded in 2000 in the United Kingdom, operates within the Health Care industry. The company is committed to its mission of generating simple, unambiguous calls to action aimed at saving lives and reducing healthcare costs.
The company develops and distributes a range of clinical decision support software, known as SaMD, which assists healthcare professionals in managing and monitoring health conditions effectively through simplification, risk identification, and prevention. Among its products are Visensia - The Safety Index and the Extubation Advisor (EA), both of which integrate advanced technology to enhance clinical outcomes and situational awareness.
Despite its long-standing presence in the market, the company’s last known investment was a £6.17K grant from SBRI Healthcare in February 2015. This could indicate a need for renewed funding strategies to continue its innovation trajectory in an increasingly competitive healthcare technology landscape.
